Illumina Body Map 2
Name | miRBASE accession |
---|---|
hsa-miR-200b-3p
|
MIMAT0000318 |
hsa-miR-200c-3p
|
MIMAT0000617 |
hsa-miR-429
|
MIMAT0001536 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_151344172 | 1.85 |
ENST00000375734.2
ENST00000263895.4 ENST00000454202.1 |
RND3
|
Rho family GTPase 3 |
chr1_+_77333117 | 1.81 |
ENST00000477717.1
|
ST6GALNAC5
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 |
chr16_+_86544113 | 1.68 |
ENST00000262426.4
|
FOXF1
|
forkhead box F1 |
chr4_+_20255123 | 1.59 |
ENST00000504154.1
ENST00000273739.5 |
SLIT2
|
slit homolog 2 (Drosophila) |
chr11_-_46940074 | 1.57 |
ENST00000378623.1
ENST00000534404.1 |
LRP4
|
low density lipoprotein receptor-related protein 4 |
chr13_-_107187462 | 1.51 |
ENST00000245323.4
|
EFNB2
|
ephrin-B2 |
chr10_+_102106829 | 1.50 |
ENST00000370355.2
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase) |
chrX_-_6146876 | 1.49 |
ENST00000381095.3
|
NLGN4X
|
neuroligin 4, X-linked |
chr1_+_201252580 | 1.47 |
ENST00000367324.3
ENST00000263946.3 |
PKP1
|
plakophilin 1 (ectodermal dysplasia/skin fragility syndrome) |
chr19_+_15218180 | 1.42 |
ENST00000342784.2
ENST00000597977.1 ENST00000600440.1 |
SYDE1
|
synapse defective 1, Rho GTPase, homolog 1 (C. elegans) |
chr4_-_6383594 | 1.38 |
ENST00000335585.5
|
PPP2R2C
|
protein phosphatase 2, regulatory subunit B, gamma |
chr3_+_181429704 | 1.36 |
ENST00000431565.2
ENST00000325404.1 |
SOX2
|
SRY (sex determining region Y)-box 2 |
chr10_-_30348439 | 1.33 |
ENST00000375377.1
|
KIAA1462
|
KIAA1462 |
chr4_-_55991752 | 1.27 |
ENST00000263923.4
|
KDR
|
kinase insert domain receptor (a type III receptor tyrosine kinase) |
chr11_+_118477144 | 1.27 |
ENST00000361417.2
|
PHLDB1
|
pleckstrin homology-like domain, family B, member 1 |
chr9_+_112403088 | 1.25 |
ENST00000448454.2
|
PALM2
|
paralemmin 2 |
chr3_+_11034403 | 1.23 |
ENST00000287766.4
ENST00000425938.1 |
SLC6A1
|
solute carrier family 6 (neurotransmitter transporter), member 1 |
chr16_-_70719925 | 1.21 |
ENST00000338779.6
|
MTSS1L
|
metastasis suppressor 1-like |
chr1_+_155099927 | 1.19 |
ENST00000368407.3
|
EFNA1
|
ephrin-A1 |
chr8_+_106330920 | 1.18 |
ENST00000407775.2
|
ZFPM2
|
zinc finger protein, FOG family member 2 |
chr19_-_46476791 | 1.18 |
ENST00000263257.5
|
NOVA2
|
neuro-oncological ventral antigen 2 |
chr1_+_199996702 | 1.17 |
ENST00000367362.3
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2 |
chr4_-_176923483 | 1.16 |
ENST00000280187.7
ENST00000512509.1 |
GPM6A
|
glycoprotein M6A |
chr3_+_50192537 | 1.13 |
ENST00000002829.3
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr20_-_48099182 | 1.11 |
ENST00000371741.4
|
KCNB1
|
potassium voltage-gated channel, Shab-related subfamily, member 1 |
chr7_-_103629963 | 1.10 |
ENST00000428762.1
ENST00000343529.5 ENST00000424685.2 |
RELN
|
reelin |
chr11_+_12695944 | 1.07 |
ENST00000361905.4
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
chr19_-_11308190 | 1.07 |
ENST00000586659.1
ENST00000592903.1 ENST00000589359.1 ENST00000588724.1 ENST00000432929.2 |
KANK2
|
KN motif and ankyrin repeat domains 2 |
chrX_+_73641286 | 1.06 |
ENST00000587091.1
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter) |
chr5_-_11904152 | 1.06 |
ENST00000304623.8
ENST00000458100.2 |
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
chr16_-_65155833 | 1.04 |
ENST00000566827.1
ENST00000394156.3 ENST00000562998.1 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
chr3_-_123603137 | 1.04 |
ENST00000360304.3
ENST00000359169.1 ENST00000346322.5 ENST00000360772.3 |
MYLK
|
myosin light chain kinase |
chr8_+_11561660 | 1.02 |
ENST00000526716.1
ENST00000335135.4 ENST00000528027.1 |
GATA4
|
GATA binding protein 4 |
chr9_-_14314066 | 1.00 |
ENST00000397575.3
|
NFIB
|
nuclear factor I/B |
chr13_+_98794810 | 0.99 |
ENST00000595437.1
|
FARP1
|
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
chr5_-_112630598 | 0.99 |
ENST00000302475.4
|
MCC
|
mutated in colorectal cancers |
chr9_-_34589700 | 0.99 |
ENST00000351266.4
|
CNTFR
|
ciliary neurotrophic factor receptor |
chr1_-_57045228 | 0.99 |
ENST00000371250.3
|
PPAP2B
|
phosphatidic acid phosphatase type 2B |
chr13_+_93879085 | 0.97 |
ENST00000377047.4
|
GPC6
|
glypican 6 |
chr22_+_48972118 | 0.96 |
ENST00000358295.5
|
FAM19A5
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5 |
chr17_+_53342311 | 0.95 |
ENST00000226067.5
|
HLF
|
hepatic leukemia factor |
chr3_-_134093395 | 0.95 |
ENST00000249883.5
|
AMOTL2
|
angiomotin like 2 |
chr1_+_66999799 | 0.95 |
ENST00000371035.3
ENST00000371036.3 ENST00000371037.4 |
SGIP1
|
SH3-domain GRB2-like (endophilin) interacting protein 1 |
chr20_+_10199468 | 0.94 |
ENST00000254976.2
ENST00000304886.2 |
SNAP25
|
synaptosomal-associated protein, 25kDa |
chrX_-_110038990 | 0.90 |
ENST00000372045.1
ENST00000394797.4 |
CHRDL1
|
chordin-like 1 |
chr8_-_13372395 | 0.90 |
ENST00000276297.4
ENST00000511869.1 |
DLC1
|
deleted in liver cancer 1 |
chr5_+_71403061 | 0.89 |
ENST00000512974.1
ENST00000296755.7 |
MAP1B
|
microtubule-associated protein 1B |
chr12_+_2162447 | 0.89 |
ENST00000335762.5
ENST00000399655.1 |
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
chr22_-_36236265 | 0.89 |
ENST00000414461.2
ENST00000416721.2 ENST00000449924.2 ENST00000262829.7 ENST00000397305.3 |
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr8_+_22224811 | 0.88 |
ENST00000381237.1
|
SLC39A14
|
solute carrier family 39 (zinc transporter), member 14 |
chr5_+_38846101 | 0.87 |
ENST00000274276.3
|
OSMR
|
oncostatin M receptor |
chr12_+_5541267 | 0.87 |
ENST00000423158.3
|
NTF3
|
neurotrophin 3 |
chr6_-_167040731 | 0.86 |
ENST00000265678.4
|
RPS6KA2
|
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
chr1_-_95392635 | 0.86 |
ENST00000538964.1
ENST00000394202.4 ENST00000370206.4 |
CNN3
|
calponin 3, acidic |
chr10_-_81205373 | 0.85 |
ENST00000372336.3
|
ZCCHC24
|
zinc finger, CCHC domain containing 24 |
chr11_+_73019282 | 0.83 |
ENST00000263674.3
|
ARHGEF17
|
Rho guanine nucleotide exchange factor (GEF) 17 |
chr11_+_120195992 | 0.83 |
ENST00000314475.2
ENST00000529187.1 |
TMEM136
|
transmembrane protein 136 |
chr8_-_89339705 | 0.82 |
ENST00000286614.6
|
MMP16
|
matrix metallopeptidase 16 (membrane-inserted) |
chr2_+_205410516 | 0.82 |
ENST00000406610.2
ENST00000462231.1 |
PARD3B
|
par-3 family cell polarity regulator beta |
chr17_-_42908155 | 0.80 |
ENST00000426548.1
ENST00000590758.1 ENST00000591424.1 |
GJC1
|
gap junction protein, gamma 1, 45kDa |
chr17_+_72983674 | 0.77 |
ENST00000337231.5
|
CDR2L
|
cerebellar degeneration-related protein 2-like |
chr1_+_183605200 | 0.77 |
ENST00000304685.4
|
RGL1
|
ral guanine nucleotide dissociation stimulator-like 1 |
chr13_-_33859819 | 0.76 |
ENST00000336934.5
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13 |
chr7_-_94285511 | 0.75 |
ENST00000265735.7
|
SGCE
|
sarcoglycan, epsilon |
chr15_-_23932437 | 0.75 |
ENST00000331837.4
|
NDN
|
necdin, melanoma antigen (MAGE) family member |
chr1_+_182992545 | 0.75 |
ENST00000258341.4
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2) |
chrX_+_114827818 | 0.75 |
ENST00000420625.2
|
PLS3
|
plastin 3 |
chr7_+_5632436 | 0.75 |
ENST00000340250.6
ENST00000382361.3 |
FSCN1
|
fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) |
chr3_-_192445289 | 0.73 |
ENST00000430714.1
ENST00000418610.1 ENST00000448795.1 ENST00000445105.2 |
FGF12
|
fibroblast growth factor 12 |
chr3_+_159557637 | 0.72 |
ENST00000445224.2
|
SCHIP1
|
schwannomin interacting protein 1 |
chr3_+_158991025 | 0.72 |
ENST00000337808.6
|
IQCJ-SCHIP1
|
IQCJ-SCHIP1 readthrough |
chr13_-_40177261 | 0.72 |
ENST00000379589.3
|
LHFP
|
lipoma HMGIC fusion partner |
chr10_+_31608054 | 0.71 |
ENST00000320985.10
ENST00000361642.5 ENST00000560721.2 ENST00000558440.1 ENST00000424869.1 ENST00000542815.3 |
ZEB1
|
zinc finger E-box binding homeobox 1 |
chr3_-_120170052 | 0.69 |
ENST00000295633.3
|
FSTL1
|
follistatin-like 1 |
chr10_-_105615164 | 0.68 |
ENST00000355946.2
ENST00000369774.4 |
SH3PXD2A
|
SH3 and PX domains 2A |
chr9_+_112810878 | 0.68 |
ENST00000434623.2
ENST00000374525.1 |
AKAP2
|
A kinase (PRKA) anchor protein 2 |
chr8_+_74206829 | 0.67 |
ENST00000240285.5
|
RDH10
|
retinol dehydrogenase 10 (all-trans) |
chr15_+_62853562 | 0.67 |
ENST00000561311.1
|
TLN2
|
talin 2 |
chr9_+_132934835 | 0.66 |
ENST00000372398.3
|
NCS1
|
neuronal calcium sensor 1 |
chr1_-_59249732 | 0.65 |
ENST00000371222.2
|
JUN
|
jun proto-oncogene |
chr5_-_95297678 | 0.65 |
ENST00000237853.4
|
ELL2
|
elongation factor, RNA polymerase II, 2 |
chr1_-_41131326 | 0.65 |
ENST00000372684.3
|
RIMS3
|
regulating synaptic membrane exocytosis 3 |
chr1_-_161059380 | 0.64 |
ENST00000368012.3
|
PVRL4
|
poliovirus receptor-related 4 |
chr5_-_45696253 | 0.63 |
ENST00000303230.4
|
HCN1
|
hyperpolarization activated cyclic nucleotide-gated potassium channel 1 |
chr1_+_25071848 | 0.63 |
ENST00000374379.4
|
CLIC4
|
chloride intracellular channel 4 |
chr12_-_15942309 | 0.63 |
ENST00000544064.1
ENST00000543523.1 ENST00000536793.1 |
EPS8
|
epidermal growth factor receptor pathway substrate 8 |
chr5_-_121413974 | 0.62 |
ENST00000231004.4
|
LOX
|
lysyl oxidase |
chr12_+_72666407 | 0.61 |
ENST00000261180.4
|
TRHDE
|
thyrotropin-releasing hormone degrading enzyme |
chr11_-_35440796 | 0.61 |
ENST00000278379.3
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr1_-_208417620 | 0.60 |
ENST00000367033.3
|
PLXNA2
|
plexin A2 |
chr8_-_22550815 | 0.60 |
ENST00000317216.2
|
EGR3
|
early growth response 3 |
chr14_+_52118576 | 0.59 |
ENST00000395718.2
ENST00000344768.5 |
FRMD6
|
FERM domain containing 6 |
chr6_+_43737939 | 0.59 |
ENST00000372067.3
|
VEGFA
|
vascular endothelial growth factor A |
chr1_-_214724566 | 0.59 |
ENST00000366956.5
|
PTPN14
|
protein tyrosine phosphatase, non-receptor type 14 |
chr14_-_35182994 | 0.57 |
ENST00000341223.3
|
CFL2
|
cofilin 2 (muscle) |
chr7_-_111846435 | 0.57 |
ENST00000437633.1
ENST00000428084.1 |
DOCK4
|
dedicator of cytokinesis 4 |
chr21_+_40177143 | 0.56 |
ENST00000360214.3
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
chr2_-_216300784 | 0.55 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
chr7_+_73703728 | 0.55 |
ENST00000361545.5
ENST00000223398.6 |
CLIP2
|
CAP-GLY domain containing linker protein 2 |
chr13_-_29069232 | 0.54 |
ENST00000282397.4
ENST00000541932.1 ENST00000539099.1 |
FLT1
|
fms-related tyrosine kinase 1 |
chr9_+_112542572 | 0.54 |
ENST00000374530.3
|
PALM2-AKAP2
|
PALM2-AKAP2 readthrough |
chr3_+_77088989 | 0.54 |
ENST00000461745.1
|
ROBO2
|
roundabout, axon guidance receptor, homolog 2 (Drosophila) |
chr9_+_2621798 | 0.54 |
ENST00000382100.3
|
VLDLR
|
very low density lipoprotein receptor |
chr2_-_166930131 | 0.53 |
ENST00000303395.4
ENST00000409050.1 ENST00000423058.2 ENST00000375405.3 |
SCN1A
|
sodium channel, voltage-gated, type I, alpha subunit |
chr13_-_30881621 | 0.53 |
ENST00000380615.3
|
KATNAL1
|
katanin p60 subunit A-like 1 |
chr7_-_132261253 | 0.53 |
ENST00000321063.4
|
PLXNA4
|
plexin A4 |
chr2_-_158485387 | 0.52 |
ENST00000243349.8
|
ACVR1C
|
activin A receptor, type IC |
chr2_+_201170703 | 0.52 |
ENST00000358677.5
|
SPATS2L
|
spermatogenesis associated, serine-rich 2-like |
chr6_-_122792919 | 0.52 |
ENST00000339697.4
|
SERINC1
|
serine incorporator 1 |
chrX_+_53078273 | 0.51 |
ENST00000332582.4
|
GPR173
|
G protein-coupled receptor 173 |
chr1_-_220101944 | 0.51 |
ENST00000366926.3
ENST00000536992.1 |
SLC30A10
|
solute carrier family 30, member 10 |
chr3_-_24536253 | 0.50 |
ENST00000428492.1
ENST00000396671.2 ENST00000431815.1 ENST00000418247.1 ENST00000416420.1 ENST00000356447.4 |
THRB
|
thyroid hormone receptor, beta |
chr7_-_82073109 | 0.50 |
ENST00000356860.3
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
chr17_-_76870222 | 0.50 |
ENST00000585421.1
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
chr8_-_93115445 | 0.49 |
ENST00000523629.1
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr3_-_167813672 | 0.49 |
ENST00000470487.1
|
GOLIM4
|
golgi integral membrane protein 4 |
chr16_+_4364762 | 0.49 |
ENST00000262366.3
|
GLIS2
|
GLIS family zinc finger 2 |
chr12_+_8850471 | 0.49 |
ENST00000535829.1
ENST00000357529.3 |
RIMKLB
|
ribosomal modification protein rimK-like family member B |
chr17_-_78450398 | 0.48 |
ENST00000306773.4
|
NPTX1
|
neuronal pentraxin I |
chr2_+_210444142 | 0.48 |
ENST00000360351.4
ENST00000361559.4 |
MAP2
|
microtubule-associated protein 2 |
chr13_+_27131887 | 0.48 |
ENST00000335327.5
|
WASF3
|
WAS protein family, member 3 |
chr2_+_206547215 | 0.48 |
ENST00000360409.3
ENST00000540178.1 ENST00000540841.1 ENST00000355117.4 ENST00000450507.1 ENST00000417189.1 |
NRP2
|
neuropilin 2 |
chr11_-_110583451 | 0.48 |
ENST00000260283.4
ENST00000528829.1 |
ARHGAP20
|
Rho GTPase activating protein 20 |
chr9_+_36036430 | 0.47 |
ENST00000377966.3
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs |
chr13_-_107220455 | 0.46 |
ENST00000400198.3
|
ARGLU1
|
arginine and glutamate rich 1 |
chr6_-_57087042 | 0.46 |
ENST00000317483.3
|
RAB23
|
RAB23, member RAS oncogene family |
chr9_-_73029540 | 0.45 |
ENST00000377126.2
|
KLF9
|
Kruppel-like factor 9 |
chr7_-_27183263 | 0.45 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
chr9_+_470288 | 0.45 |
ENST00000382303.1
|
KANK1
|
KN motif and ankyrin repeat domains 1 |
chr3_-_185826855 | 0.44 |
ENST00000306376.5
|
ETV5
|
ets variant 5 |
chr11_-_66115032 | 0.44 |
ENST00000311181.4
|
B3GNT1
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 |
chr4_+_156588350 | 0.43 |
ENST00000296518.7
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr14_-_105635090 | 0.43 |
ENST00000331782.3
ENST00000347004.2 |
JAG2
|
jagged 2 |
chr5_-_41510656 | 0.43 |
ENST00000377801.3
|
PLCXD3
|
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
chr10_+_96162242 | 0.42 |
ENST00000225235.4
|
TBC1D12
|
TBC1 domain family, member 12 |
chr12_-_8088871 | 0.42 |
ENST00000075120.7
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3 |
chr5_+_129240151 | 0.41 |
ENST00000305031.4
|
CHSY3
|
chondroitin sulfate synthase 3 |
chr2_-_164592497 | 0.41 |
ENST00000333129.3
ENST00000409634.1 |
FIGN
|
fidgetin |
chr14_+_67826709 | 0.41 |
ENST00000256383.4
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa |
chr20_+_58152524 | 0.41 |
ENST00000359926.3
|
PHACTR3
|
phosphatase and actin regulator 3 |
chr12_-_47219733 | 0.40 |
ENST00000547477.1
ENST00000447411.1 ENST00000266579.4 |
SLC38A4
|
solute carrier family 38, member 4 |
chr5_-_57756087 | 0.40 |
ENST00000274289.3
|
PLK2
|
polo-like kinase 2 |
chr7_+_119913688 | 0.40 |
ENST00000331113.4
|
KCND2
|
potassium voltage-gated channel, Shal-related subfamily, member 2 |
chr12_+_1800179 | 0.39 |
ENST00000357103.4
|
ADIPOR2
|
adiponectin receptor 2 |
chr7_-_41742697 | 0.39 |
ENST00000242208.4
|
INHBA
|
inhibin, beta A |
chr12_-_8815404 | 0.38 |
ENST00000359478.2
ENST00000396549.2 |
MFAP5
|
microfibrillar associated protein 5 |
chr19_+_34745442 | 0.38 |
ENST00000299505.6
ENST00000588470.1 ENST00000589583.1 ENST00000588338.2 |
KIAA0355
|
KIAA0355 |
chr13_-_84456527 | 0.38 |
ENST00000377084.2
|
SLITRK1
|
SLIT and NTRK-like family, member 1 |
chr5_-_44388899 | 0.38 |
ENST00000264664.4
|
FGF10
|
fibroblast growth factor 10 |
chr6_-_154831779 | 0.37 |
ENST00000607772.1
|
CNKSR3
|
CNKSR family member 3 |
chr6_+_1389989 | 0.37 |
ENST00000259806.1
|
FOXF2
|
forkhead box F2 |
chr2_-_47168906 | 0.37 |
ENST00000444761.2
ENST00000409147.1 |
MCFD2
|
multiple coagulation factor deficiency 2 |
chr2_+_39893043 | 0.36 |
ENST00000281961.2
|
TMEM178A
|
transmembrane protein 178A |
chr1_+_200708671 | 0.36 |
ENST00000358823.2
|
CAMSAP2
|
calmodulin regulated spectrin-associated protein family, member 2 |
chr14_-_53417732 | 0.36 |
ENST00000399304.3
ENST00000395631.2 ENST00000341590.3 ENST00000343279.4 |
FERMT2
|
fermitin family member 2 |
chr1_+_3607228 | 0.36 |
ENST00000378285.1
ENST00000378280.1 ENST00000378288.4 |
TP73
|
tumor protein p73 |
chr2_-_73053126 | 0.36 |
ENST00000272427.6
ENST00000410104.1 |
EXOC6B
|
exocyst complex component 6B |
chr1_-_8086343 | 0.35 |
ENST00000474874.1
ENST00000469499.1 ENST00000377482.5 |
ERRFI1
|
ERBB receptor feedback inhibitor 1 |
chr15_+_59063478 | 0.35 |
ENST00000559228.1
ENST00000450403.2 |
FAM63B
|
family with sequence similarity 63, member B |
chr2_-_193059634 | 0.35 |
ENST00000392314.1
|
TMEFF2
|
transmembrane protein with EGF-like and two follistatin-like domains 2 |
chr6_-_80247105 | 0.35 |
ENST00000369846.4
|
LCA5
|
Leber congenital amaurosis 5 |
chr12_+_79258547 | 0.34 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
chr9_+_34990219 | 0.34 |
ENST00000541010.1
ENST00000454002.2 ENST00000545841.1 |
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
chr2_+_28615669 | 0.34 |
ENST00000379619.1
ENST00000264716.4 |
FOSL2
|
FOS-like antigen 2 |
chr5_-_171433819 | 0.32 |
ENST00000296933.6
|
FBXW11
|
F-box and WD repeat domain containing 11 |
chr10_-_98273668 | 0.32 |
ENST00000357947.3
|
TLL2
|
tolloid-like 2 |
chr1_-_52456352 | 0.32 |
ENST00000371655.3
|
RAB3B
|
RAB3B, member RAS oncogene family |
chr11_-_123525289 | 0.32 |
ENST00000392770.2
ENST00000299333.3 ENST00000530277.1 |
SCN3B
|
sodium channel, voltage-gated, type III, beta subunit |
chr10_-_52645416 | 0.31 |
ENST00000374001.2
ENST00000373997.3 ENST00000373995.3 ENST00000282641.2 ENST00000395495.1 ENST00000414883.1 |
A1CF
|
APOBEC1 complementation factor |
chr1_+_64936428 | 0.31 |
ENST00000371073.2
ENST00000290039.5 |
CACHD1
|
cache domain containing 1 |
chr7_-_35077653 | 0.31 |
ENST00000310974.4
|
DPY19L1
|
dpy-19-like 1 (C. elegans) |
chr18_-_53255766 | 0.31 |
ENST00000566286.1
ENST00000564999.1 ENST00000566279.1 ENST00000354452.3 ENST00000356073.4 |
TCF4
|
transcription factor 4 |
chr12_-_123011536 | 0.31 |
ENST00000331738.7
ENST00000354654.2 |
RSRC2
|
arginine/serine-rich coiled-coil 2 |
chr3_+_44379944 | 0.30 |
ENST00000396078.3
ENST00000342649.4 |
TCAIM
|
T cell activation inhibitor, mitochondrial |
chr8_+_70378852 | 0.29 |
ENST00000525061.1
ENST00000458141.2 ENST00000260128.4 |
SULF1
|
sulfatase 1 |
chr18_-_45663666 | 0.29 |
ENST00000535628.2
|
ZBTB7C
|
zinc finger and BTB domain containing 7C |
chr1_+_202317815 | 0.29 |
ENST00000608999.1
ENST00000336894.4 ENST00000480184.1 |
PPP1R12B
|
protein phosphatase 1, regulatory subunit 12B |
chr7_-_75988321 | 0.29 |
ENST00000307630.3
|
YWHAG
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma |
chr2_-_86564776 | 0.29 |
ENST00000165698.5
ENST00000541910.1 ENST00000535845.1 |
REEP1
|
receptor accessory protein 1 |
chr7_+_29234028 | 0.28 |
ENST00000222792.6
|
CHN2
|
chimerin 2 |
chr16_-_2185899 | 0.28 |
ENST00000262304.4
ENST00000423118.1 |
PKD1
|
polycystic kidney disease 1 (autosomal dominant) |
chr15_-_49447835 | 0.28 |
ENST00000388901.5
ENST00000299259.6 |
COPS2
|
COP9 signalosome subunit 2 |
chr5_+_149887672 | 0.28 |
ENST00000261797.6
|
NDST1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
chr10_+_133918175 | 0.28 |
ENST00000298622.4
|
JAKMIP3
|
Janus kinase and microtubule interacting protein 3 |
chr11_-_119599794 | 0.28 |
ENST00000264025.3
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
chr20_-_23402028 | 0.28 |
ENST00000398425.3
ENST00000432543.2 ENST00000377026.4 |
NAPB
|
N-ethylmaleimide-sensitive factor attachment protein, beta |
chr7_-_42276612 | 0.27 |
ENST00000395925.3
ENST00000437480.1 |
GLI3
|
GLI family zinc finger 3 |
chr6_+_30687978 | 0.27 |
ENST00000327892.8
ENST00000435534.1 |
TUBB
|
tubulin, beta class I |
chr13_-_103451307 | 0.27 |
ENST00000376004.4
|
KDELC1
|
KDEL (Lys-Asp-Glu-Leu) containing 1 |
chr10_-_102279586 | 0.27 |
ENST00000370345.3
ENST00000451524.1 ENST00000370329.5 |
SEC31B
|
SEC31 homolog B (S. cerevisiae) |
chr4_+_141294628 | 0.27 |
ENST00000512749.1
ENST00000608372.1 ENST00000506597.1 ENST00000394201.4 ENST00000510586.1 |
SCOC
|
short coiled-coil protein |
chr17_-_53499310 | 0.27 |
ENST00000262065.3
|
MMD
|
monocyte to macrophage differentiation-associated |
chr8_-_48651648 | 0.25 |
ENST00000408965.3
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta |
chr12_-_31744031 | 0.25 |
ENST00000389082.5
|
DENND5B
|
DENN/MADD domain containing 5B |
chr6_+_17600576 | 0.25 |
ENST00000259963.3
|
FAM8A1
|
family with sequence similarity 8, member A1 |
chr11_+_111807863 | 0.25 |
ENST00000440460.2
|
DIXDC1
|
DIX domain containing 1 |
chr3_-_98620500 | 0.25 |
ENST00000326840.6
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2 |
chr14_-_27066636 | 0.25 |
ENST00000267422.7
ENST00000344429.5 ENST00000574031.1 ENST00000465357.2 ENST00000547619.1 |
NOVA1
|
neuro-oncological ventral antigen 1 |
chr16_+_9185450 | 0.24 |
ENST00000327827.7
|
C16orf72
|
chromosome 16 open reading frame 72 |
chr8_-_74884511 | 0.24 |
ENST00000518127.1
|
TCEB1
|
transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) right lung development(GO:0060458) |
0.5 | 1.6 | GO:0090024 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.5 | 1.6 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.5 | 1.5 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.4 | 1.2 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.3 | 1.2 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.3 | 1.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 1.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.3 | 0.8 | GO:0060435 | bronchiole development(GO:0060435) |
0.3 | 1.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.2 | 1.5 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.2 | 0.9 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.2 | 1.9 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.2 | 0.6 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.2 | 1.4 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.2 | 0.5 | GO:1904235 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
0.2 | 0.9 | GO:0048749 | compound eye development(GO:0048749) |
0.2 | 0.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 2.5 | GO:0003360 | brainstem development(GO:0003360) |
0.2 | 0.5 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
0.2 | 0.5 | GO:1901383 | negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
0.2 | 1.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 1.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 | 0.4 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.1 | 1.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.8 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.1 | 0.4 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 0.1 | GO:0061227 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
0.1 | 1.0 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.1 | 0.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.1 | 0.7 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 1.4 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.1 | 2.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.3 | GO:0045720 | negative regulation of integrin biosynthetic process(GO:0045720) |
0.1 | 0.7 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.9 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.1 | 0.7 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.1 | 0.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.5 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.1 | 1.6 | GO:0097490 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.1 | 0.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 0.4 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.1 | 0.1 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
0.1 | 0.5 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.3 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.1 | 0.7 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.1 | 0.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 1.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.5 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 2.2 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.5 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.1 | 0.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.5 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.1 | 0.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.6 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.1 | 1.0 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.4 | GO:0008050 | female courtship behavior(GO:0008050) |
0.1 | 0.5 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.1 | 0.2 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.1 | 1.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.5 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.4 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.7 | GO:0048752 | negative regulation of endothelial cell differentiation(GO:0045602) semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.5 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.1 | 0.3 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
0.1 | 0.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.7 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.6 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.6 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.2 | GO:0008057 | eye pigment granule organization(GO:0008057) |
0.1 | 0.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 1.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.3 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.1 | 1.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.6 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.5 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.1 | 1.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.3 | GO:0060686 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.0 | 1.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.9 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
0.0 | 0.1 | GO:1904586 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
0.0 | 0.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.5 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.0 | 0.2 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
0.0 | 0.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.2 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.0 | 0.2 | GO:2001076 | thorax and anterior abdomen determination(GO:0007356) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.0 | 0.1 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.0 | 0.1 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.0 | 0.9 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.2 | GO:0018032 | protein amidation(GO:0018032) |
0.0 | 0.4 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.0 | 0.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.0 | 0.1 | GO:1904170 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
0.0 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.0 | 0.6 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.0 | 0.5 | GO:0061042 | vascular wound healing(GO:0061042) |
0.0 | 0.7 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.7 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.0 | 0.1 | GO:0061145 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
0.0 | 0.1 | GO:0007388 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
0.0 | 0.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.0 | 0.3 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.0 | 0.6 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.0 | 0.1 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.0 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.3 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 2.0 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.1 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) intestinal epithelial cell migration(GO:0061582) |
0.0 | 0.2 | GO:0048619 | hindgut morphogenesis(GO:0007442) embryonic hindgut morphogenesis(GO:0048619) |
0.0 | 0.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.1 | GO:1903912 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.0 | 0.1 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.0 | 0.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.2 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 1.4 | GO:0097178 | ruffle assembly(GO:0097178) |
0.0 | 0.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.0 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.0 | 0.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.7 | GO:0003016 | respiratory system process(GO:0003016) |
0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.4 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.1 | GO:0046833 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
0.0 | 0.0 | GO:0060948 | coronary vein morphogenesis(GO:0003169) cardiac vascular smooth muscle cell development(GO:0060948) |
0.0 | 0.0 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.0 | 0.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.9 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.4 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.0 | 0.1 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
0.0 | 0.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.1 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.0 | 0.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.2 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.7 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.1 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.0 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.0 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.0 | 0.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.0 | 0.0 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.0 | 0.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.0 | 0.1 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.3 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.1 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
0.0 | 0.0 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.0 | 0.1 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.0 | 0.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 0.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.0 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.0 | 0.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.2 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.1 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.0 | 0.4 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.9 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.1 | GO:0050773 | regulation of dendrite development(GO:0050773) |
0.0 | 0.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.1 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.9 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.2 | 0.6 | GO:0098855 | HCN channel complex(GO:0098855) |
0.2 | 1.0 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.2 | 1.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 1.1 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 0.7 | GO:0005606 | laminin-1 complex(GO:0005606) laminin-11 complex(GO:0043260) |
0.1 | 0.7 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.4 | GO:0043614 | multi-eIF complex(GO:0043614) translation preinitiation complex(GO:0070993) glial limiting end-foot(GO:0097451) |
0.1 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 1.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 0.4 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.1 | 1.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 1.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 1.5 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.8 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.2 | GO:0000806 | Y chromosome(GO:0000806) cyclin E1-CDK2 complex(GO:0097134) |
0.1 | 0.7 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 0.3 | GO:0002133 | polycystin complex(GO:0002133) |
0.1 | 1.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.9 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.5 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.0 | 0.3 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.0 | 1.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 1.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 1.0 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 0.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.8 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.2 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.0 | 0.7 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.1 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.0 | 0.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 1.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.1 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.0 | 1.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.5 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 0.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:0043219 | lateral loop(GO:0043219) |
0.0 | 0.7 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.7 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.2 | GO:0016013 | syntrophin complex(GO:0016013) |
0.0 | 0.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 2.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.4 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 2.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 0.2 | GO:0030054 | cell junction(GO:0030054) |
0.0 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 1.1 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.7 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.6 | GO:0032420 | stereocilium(GO:0032420) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 1.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 0.5 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.2 | 1.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 0.5 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 0.5 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.2 | 1.5 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.2 | 0.5 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 0.5 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
0.2 | 1.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.5 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
0.1 | 0.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 1.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 2.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.8 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.1 | 0.4 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.1 | 0.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 1.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 1.0 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.1 | 1.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.6 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 0.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 1.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 1.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.2 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
0.1 | 0.3 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.1 | 0.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.9 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 1.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 1.5 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 1.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.2 | GO:0032451 | demethylase activity(GO:0032451) histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.0 | 0.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.2 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.0 | 0.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.0 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 1.0 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 1.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 0.2 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 1.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.5 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 1.1 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 1.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 1.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 1.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0010736 | serum response element binding(GO:0010736) |
0.0 | 0.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.0 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.0 | 3.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 0.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.0 | 0.3 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.5 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.7 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.3 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 1.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.0 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 2.1 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 1.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 2.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 1.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 2.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 1.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 1.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 1.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 1.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 2.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 1.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 1.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 1.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 1.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 1.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 1.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 1.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 3.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.6 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 1.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.5 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |